Literature DB >> 19553593

Submandibular TCD approach detects post-bulb ICA stenosis in children with sickle cell anemia.

Mark J Gorman1, Karin Nyström, Judith Carbonella, Howard Pearson.   

Abstract

BACKGROUND: Transcranial Doppler (TCD) ultrasound is a procedure commonly used to screen individuals with the major hemoglobin S diseases, Hb SS and Hb S-beta(0), for significant stenoses in the circle of Willis. Flow velocities above 200 cm/s have been shown to identify patients at elevated risk for cerebral infarction. Among TCD's limitations is the inability to insonate the distal extracranial, petrous, and cavernous internal carotid artery (ICA) through the standard transtemporal approach.
METHODS: We extended the submandibular approach to include infra-siphon portions of the ICA.
RESULTS: Using the extended submandibular approach to evaluate these portions of the ICA, we identified stenotic lesions in 4 patients with Hb SS disease out of a population of 131 children with Hb SS. Three of the 4 patients had no history of overt stroke or stroke-like symptoms. Neuroimaging confirmed the stenotic lesions, and also revealed watershed infarction as well as discrete areas of silent infarction. All 4 children had neuropsychological impairment.
CONCLUSIONS: The submandibular approach, when added to a standard transcranial Doppler examination, may increase the sensitivity of this technique to identify important potential sources of cerebral infarction.

Entities:  

Mesh:

Year:  2009        PMID: 19553593     DOI: 10.1212/WNL.0b013e3181ae2361

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Extracranial internal carotid artery stenosis in children with sickle cell disease - Which transducer, what measurement?

Authors:  Colin R Deane; Benjamin J Freedman; Susan E Height; David C Rees
Journal:  Ultrasound       Date:  2016-03-16

2.  Extracranial internal carotid arterial disease in children with sickle cell anemia.

Authors:  Colin R Deane; David Goss; Jack Bartram; Keith R E Pohl; Susan E Height; Naomi Sibtain; Jozef Jarosz; Swee Lay Thein; David C Rees
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

Review 3.  Prospects for primary stroke prevention in children with sickle cell anaemia.

Authors:  Lori C Jordan; James F Casella; Michael R DeBaun
Journal:  Br J Haematol       Date:  2012-01-09       Impact factor: 6.998

4.  Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact.

Authors:  Sawsan M Moeen; Ahmad F Thabet; Hosam A Hasan; Medhat A Saleh
Journal:  Indian J Hematol Blood Transfus       Date:  2017-04-08       Impact factor: 0.900

5.  Extracranial carotid arteriopathy in stroke-free children with sickle cell anemia: detection by submandibular Doppler sonography.

Authors:  Suzanne Verlhac; Stéphane Balandra; Isabelle Cussenot; Florence Kasbi; Manuela Vasile; Ahmed Kheniche; Monique Elmaleh-Bergès; Ghislaine Ithier; Malika Benkerrou; Françoise Bernaudin; Guy Sebag
Journal:  Pediatr Radiol       Date:  2014-03-06

6.  Incidence, kinetics, and risk factors for intra- and extracranial cerebral arteriopathies in a newborn sickle cell disease cohort early assessed by transcranial and cervical color Doppler ultrasound.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Fouad Madhi; Camille Jung; Ralph Epaud; Suzanne Verlhac
Journal:  Front Neurol       Date:  2022-09-14       Impact factor: 4.086

7.  Intracranial and Extracranial Vascular Stenosis as Risk Factors for Stroke in Sickle Cell Disease.

Authors:  Alyssa A Schlotman; Manus J Donahue; Adetola A Kassim; Chelsea A Lee; Spencer L Waddle; Sumit Pruthi; L Taylor Davis; Mark Rodeghier; Michael R DeBaun; Lori C Jordan
Journal:  Pediatr Neurol       Date:  2020-10-22       Impact factor: 3.372

Review 8.  Why, Who, When, and How? Rationale for Considering Allogeneic Stem Cell Transplantation in Children with Sickle Cell Disease.

Authors:  Françoise Bernaudin
Journal:  J Clin Med       Date:  2019-09-22       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.